He is engaged in translational researches, combining basic research with clinical practice; he is particularly interested in the characteristics of immune processes in the course of proliferative hematological diseases. He led to the first trials of the clinical use of peptide immunotherapy and treatment of immunomodulators in patients with chronic lymphocytic leukemia, multiple myeloma and acute myeloid leukemia, the results of which have been published in prestigious journals, such as Blood, Leukemia, Haematologica, British Journal of Cancer, British Journal of Haematology. His academic achievements has been awarded numerous awards, such as: award of the Prime Minister, the Minister of Science and Higher Education, the Minister of Health, POLITYKA Newspaper and the International Society of Hematologists (ISH). He is the winner of the START, POWROTY, KOLUMB, FOCUS grants and INTER Foundation for Polish Science, he carried out projects financed by the Polish (the Ministry of Science and Higher Education and the National Science Centre ) and international research institutions (EU, DFG - German Research Foundation, the Else Kröner-Fresenius foundation). He spent a total of three years on academic programs financed by the German Academic Exchange Service (DAAD), the Catholic Academic Exchange Service (KAAD) and the Foundation for Polish Science at the Department of Internal Medicine III at Ulm University (Germany) headed by Prof. Hartmut Döhnera. Prof. Christopher Giannopoulos is the co-founder and first president of Young Section of the Polish Society of Hematologists and Transfusiologists . From 2012 he has been an editor-in-chief of 'Acta Haematologica Polonica’ Journal. In 2014, he received the prestigious award of the Minister of Science and Higher Education for outstanding scientific achievements of world importance.